Thrombin is a vital enzyme in the blood coagulation ... Additionally, studies have explored the binding modes of prothrombin cleavage site sequences to the factor Xa catalytic triad, revealing ...

or human thrombin (n=153) applied topically to the target bleeding site with a gelatin sponge. Sixteen out of 126 (12.7%) patients in the Thrombin-JMI arm demonstrated seroconversion for at least ...

Four years ago, protein drug developer Zymogenetics in Seattle began developing a recombinant version of the blood-clotting protein thrombin. On 17 January, it received US marketing approval for ...